CBTP Welcomes Summer Interns 2026

February 1, 2026 - Weill Cornell Medicine investigators have received a $100,000 grant from the GC Global consortium to study diffuse pediatric brain tumors, including gliomatosis cerebri. The project will develop standardized tools combining imaging and molecular data to better understand how these tumors spread through the brain.

AACR ADVOCACY DAYS 2026

May 14, 2026 -CBTP Program Director Cindy Campbell joined the American Association for Cancer Research (AACR) and colleagues to advocate for sustained federal investment in cancer research. They met with NYS representatives to highlight the importance of continued support for scientific discovery.

CED Trial Funding from Cure Starts Now

APRIL 15, 2026 -Dr. Mark Souweidane has received a grant from The Cure Starts Now Foundation and partners to support a Phase 1a clinical trial testing 177Lu-DTPA-omburtamab in children and young adults with DMG, including DIPG. This next-generation approach combines precision radioimmunotherapy with real-time imaging to evaluate safety, dosing, and drug distribution in the tumor.

Cancer Research

MAY 24, 2026 - A new study was published in Cancer Research highlighting how limited genetic ancestral diversity in preclinical models may influence treatment and outcomes in pediatric brain tumor patients. The authors call for more inclusive research systems to ensure future therapies are effective for all children.

GC GLOBAL AWARDS CBTP $100,000

February 1, 2026 - Weill Cornell Medicine investigators have received a $100,000 grant from the GC Global consortium to study diffuse pediatric brain tumors, including gliomatosis cerebri. The project will develop standardized tools combining imaging and molecular data to better understand how these tumors spread through the brain.

Go to Top